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Abstract
Purpose: To assess the long-term association of military combat stress with coronary heart disease
(CHD) and ischemic stroke (IS).
Methods: The association between exposure to military combat and the occurrence of CHD and IS
was assessed among 5,347 men in the Atherosclerosis Risk in Communities (ARIC) study. Outcomes
were assessed an average of 36 years after entry into military service during the eras of World War
II, the Korean War and the Vietnam conflict.
Results: Veterans were more likely to be older, white and of higher socioeconomic status than non-
veterans. No differences in CHD period prevalence rates were noted among the three exposure
groups, overall or by era of service. Associations between combat and ischemic stroke period
prevalence may be modified by father’s education, although confidence intervals were wide and
event rates small.
Conclusions: Overall, middle-aged veterans with distant combat exposure are not at increased
cardiovascular risk compared to those without combat exposure.
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INTRODUCTION
Military service can have positive as well as negative consequences (1,2) and both short-term
and long-term effects.(3,4) The psychosocial stress experienced by veterans with a history of
active combat has both psychological and physical components.(3,5) Approximately 65% of
American men over the age of 55 served in World War II or the Korean conflict and about
25% of older American men were exposed to combat early in their lives. (3,6) Yet the long-
term effects of associated exposures are so little studied that they are considered a “hidden
variable” in the aging of older American men. (2,3) Studies report higher rates of adverse
behaviors, (7) psychological conditions (8) and self-reported health conditions (9,10) among
those with combat exposure. However, studies of the long-term cardiovascular consequences
of combat stress are limited, and inconclusive. (3,11) We report on the association between
exposure to military combat and coronary heart disease (CHD) and ischemic stroke (IS) in a
community-based sample of men serving during the eras of World War II, the Korean War and
the Vietnam Conflict.
METHODS
Study population
The Atherosclerosis Risk in Communities (ARIC) Study is a community-based study designed
to investigate the etiology of cardiovascular disease (CVD) and atherosclerosis. At baseline
(1987–1989), there were 15,792 African-American and Caucasian men and women ages of 45
to 64 years, sampled from four U.S. communities: Minneapolis, MN; Washington County,
MD; Jackson, MS; and Forsyth County, NC. Participants from MN and MD were Caucasian;
African-American participants were sampled exclusively in MS. The NC center included both
African-American and Caucasian participants with an over-sampling of African-Americans.
At baseline, standardized interviews obtained health history, sociodemographic and behavioral
risk data. Trained and certified technicians performed standardized physical exams and
subclinical CVD measurements and collected fasting blood samples. Detailed design and
procedures information is published, (12,13) and quality control and study protocol information
is available at http://www.cscc.unc.edu/aric. Participants underwent three additional triennial
examinations, the last occurring in 1997–1999. Survivors are contacted annually to ascertain
vital status, health status and hospitalizations, with a 94% success rate.
Ancillary to ARIC, the Life Course Socioeconomic Status, Social Context and Cardiovascular
Disease (LC-SES) Study was initiated in 2001 to examine the association between SES across
the life course and adult cardiovascular conditions. Participants were also asked about military
and combat exposures. Detailed design and procedures information is published (14) and
available at http://www.lifecourseepi.info. An average of fifteen years after baseline, cohort
survivors were between 57 and 79 years old. The LC-SES interview included 12,716
participants, representing 81% of baseline ARIC participants and 91% of cohort survivors.
Exclusions
Because only 49 women LC-SES participants reported military service, this study was limited
to men. Because testing of modification by race was of interest, men with a race other than
African-American or Caucasian (n=14) and African-Americans from Washington County or
Minneapolis (n=21) were excluded due to limited numbers. Further excluded were 53 men
with missing/unknown military service status, leaving 5,347 men for analyses.
Military service and combat exposures
During the LC-SES interview, participants were asked about military service. Participants
reporting service were further queried about: [1] age at entry, [2] years of service, and whether
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they [3] served in a combat zone, [4] were ever under fire or fired at the enemy, [5] saw others
wounded or killed or [6] were ever wounded or missing in action. (15) Combat exposure was
established based on a positive response to one or more of questions 3–6. A three-level exposure
variable was derived: no history of military service (non-veterans), history of military service
without exposure to combat (non-combat veterans) and history of military service with
exposure to combat (combat veterans). Combat and non-combat veterans were each compared
separately to non-veterans, and, independently, combat and non-combat veterans were
compared to one another in analyses that excluded non-veterans.
Era of service was determined using age at entry and duration of service. Veterans served
during the eras of World War II (1941–1945), the Korean War (1950–1953) and the Vietnam
Conflict (1961–1975). Veterans who served during multiple conflict eras were categorized
using their first era of service, as this was their initial, and possibly defining, military
experience. Veterans who served between periods of defined conflict were included in total
analyses but were not grouped into a discrete category for era-specific analyses, as they were
deemed too heterogeneous to provide meaningful results.
Risk factors
Cardiovascular risk factors measured at baseline included total cholesterol, high density
lipoprotein (HDL) cholesterol, current smoking status, systolic blood pressure (SBP), use of
BP medications in the past two weeks, prevalent diabetes mellitus, and left ventricular
hypertrophy (LVH). Plasma total cholesterol (mg/dL) was measured using an established
enzymatic method, (16) and HDL cholesterol (mg/dL) was measured after dextran-magnesium
precipitation of non-high density lipoproteins. (17) Smoking status and use of blood pressure
medications was based on self-report. (18) Three seated BP measurements were taken with a
random-zero mercury sphygmomanometer, and the average of the last two measurements used.
Prevalent diabetes was defined as a fasting glucose level ≥126 mg/dL, a non-fasting glucose
level ≥200 mg/dL or a self-reported diagnosis of diabetes or use of diabetic medication. LVH
by electrocardiography was defined by the Cornell score. (19,20)
Baseline sociodemographic factors included age, self-reported race and highest level of
education (< high school; high school or equivalent; > high school). Childhood SES was
measured by father’s highest level of education, reported at the LC-SES interview.
CHD and IS events
Detailed descriptions of the methods of ascertainment of CHD and IS events have been
published. (21,22) Briefly, events were ascertained by annual follow-up interview and
surveillance of hospital discharges in the ARIC study areas and validated by abstraction of
hospital discharge records and death certificates followed by classification according to ARIC
study criteria that include trained physician reviewers. (23,24) Out-of-hospital deaths were
ascertained through death certificates and, when available, coroner or autopsy reports. Events
were included from enrollment in ARIC (1987–1989) until December 31, 2004.
A CHD event was defined as a validated definite or probable hospitalized myocardial infarction
(based on a combination of chest pain symptoms, ECG changes, and cardiac enzyme levels)
or a definite MI or CHD death (based on chest pain symptoms, underlying death certificate
cause of death, and other information from the hospital chart, medical history or ARIC visit),
or a silent MI by electrocardiography. An IS event was defined as a validated definite or
probable hospitalized embolic or thrombotic stroke, classified according to symptom type,
duration and severity as well as results of neuroimaging and other diagnostic procedures and
autopsy evidence, when available. (25,26)
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Statistical analysis
Baseline distributions of military experiences and socioeconomic and CVD risk factors were
presented separately for the three exposure groups and compared using Student t-tests for
continuous variables and chi-square tests for categorical variables. Period prevalence (PP) rates
were calculated by dividing the number of events by the total time experienced for the
participants followed. PP rate ratios (PPR) and 95% confidence intervals (CI) were calculated
using Poisson regression, (27) with CHD and stroke event rates were modeled on a logarithmic
scale as a function of military and combat exposure status. Two models were fit for each
outcome (CHD and IS): one model comparing combat and non-combat veterans with a non-
veteran referent and a second model comparing combat veterans to a non-combat veteran
referent.
PPRs and 95% CIs were derived using a backward elimination strategy. First,
sociodemographic factors shown in Table 1 were included to assess interaction and
confounding, where appropriate, for consideration in full models. For models comparing the
two veteran groups, era and duration of service were also tested for confounding and
interaction. Because of the likelihood that physiologic risk factors presented in Table 2 were
involved as intermediates, such variables were not assessed as confounders, (28) as
conditioning on intermediates can lead to biased estimates of total effects. (29) Variables were
included in full models if adjustment resulted in a 10% or greater change in estimate. Inclusion
of variables in the final models was based on results of p<0.1 for -2 Log Likelihood tests for
interaction terms and change in estimate of 10% or more for confounders. SAS statistical
software Version 8.02 was used for all analyses. (30)
RESULTS
This study included 5,347 men: 2,042 non-veterans, 2,127 non-combat veterans and 1,178
combat veterans. Combat veterans were more likely to have served during World War II than
noncombat veterans (41% vs. 15%) and less likely to have served during the Vietnam Conflict
(17% vs. 24%; Table 1). Compared to non-combat veterans, combat veterans’ mean age at
induction was approximately one year younger (19 vs. 20 years) and mean duration of service
was almost 2 years longer (3 vs. 5 years). Service in a combat zone was the most commonly
reported combat exposure (83%), followed by having seen others wounded or killed during
the war (73%), and having been under fire or fired at the enemy (60%). Only 13% of combat
veterans reported having been wounded or missing during war.
Veterans were older and more likely to be white and of higher SES than non-veterans (Table
2). Compared to non-veterans, both combat and non-combat veterans were less likely to
currently smoke than non-veterans (p<0.01), less likely to have prevalent LVH (p=0.07 and
0.02, respectively), and less likely to have elevated SBP (p<0.01). Non-combat veterans were
less likely to be diabetic than either non-veterans (p<0.01) or combat veterans (p=0.01).
Compared to both non-veterans and non-combat veterans, combat veterans had the highest
average total cholesterol (p=0.01 and 0.05) and the lowest average HDL cholesterol (p<0.01
and <0.01).
From 1987 through 2004, 632 validated definite and probable CHD events occurred (Table 3),
representing 11.6% of non-veterans, 11.3% of non-combat veterans and 13.2% of combat
veterans. For models with a non-veteran referent, both full and final models included baseline
age and adult education. For the model with a non-combat referent, duration of service dropped
out during model selection, leaving a full model with only baseline age. There were no
significant differences in CHD rates between non-combat veterans compared to non-veterans
or between combat veterans compared to non-veterans (Table 3). When the two veteran groups
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were compared, although tests of homogeneity suggested difference in effect by era and
although the direction of effects differed by era, CIs overlapped considerably.
From 1987 through 2004, 234 validated IS events occurred, representing 4.4% of non-veterans,
3.7% of non-combat veterans and 5.7% of combat veterans. The full model with a non-veteran
referent included baseline age, race, adult education, father’s education and interactions with
father’s education and race. The final model included baseline age, father’s education and
interaction with race. Although the interaction with race was significant, CIs overlapped
considerably; therefore, combined results are presented. For the model with a non-combat
veteran referent, the full model included baseline age and interactions with father’s education
and era of service, while the final model included only baseline age and interaction with father’s
education.
Although both combat and non-combat veterans had elevated IS rates compared to non-
veterans in adjusted analyses (Table 4), CIs overlapped considerably. When the two veteran
groups were compared, among veterans whose fathers had less than a high school education,
IS PP rates were 79% higher among combat veterans, even after age adjustment (95% CI: 1.10–
2.91).
DISCUSSION
Our study suggests that middle-aged veterans with a history of distant combat exposure are
not at increased cardiovascular risk compared to those without combat exposure. Similarly,
studies of Vietnam Conflict veterans comparing theater and non-theater veterans reported no
significant differences in circulatory disorder mortality rates 20–30 years post-service (31–
34) or in relative risks of circulatory disease 16 years post-service. (35) A study of World War
II and Korean War veterans, however, reported higher heart disease and stroke mortality among
prisoners of war (POW) compared to both non-POW veterans and non-veterans 50 years post-
service. (36) Additionally, combat was associated with increased chronic disease mortality 15
years post-service in a cohort of World War II veterans. (9) Methodological differences (e.g.,
varying exposure definitions, endpoints, covariate adjustment, follow-up times, study designs
and populations) complicate the establishment of a clear consensus.
Although veterans’ CHD risk was not elevated in our study, an alternative explanation may be
provided by the “healthy-warrior effect,” whereby servicemen tend to be healthier than
civilians due to military selection requirements. (37) Accordingly, the lack of a finding of
improved health among veterans may suggest that health status was diminished as a result of
military service. However, the lack of a difference in CHD risk between combat and non-
combat veterans suggests that combat exposure is not associated with increased CHD risk.
Consistent with earlier reports, (38,39) combat and IS risk are positively associated only among
men with low SES fathers. Childhood SES can influence both military factors (e.g., military
service, rank and combat exposure) and health factors (e.g., skills and resources to cope with
stress, health behaviors). Adult SES may be influenced by military service (e.g., education
during or after service through government opportunities and benefits). Some postulate that
combat exposure positively or neutrally affects people with a higher pre-military SES and
negatively affects those with lower pre-military SES. (40) Accordingly, persons with fewer
social and economic resources have more difficulty overcoming the negative effects of a
traumatic life, while those from more privileged backgrounds are less negatively or even
positively affected by combat. Although confidence intervals are wide and event rates small,
our results are consistent with the hypothesis that men who entered the military at a
socioeconomic disadvantage were more negatively affected by combat exposure than those
with more resources.
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Strengths and limitations
Key advantages of this study include validated cardiovascular risk factor and outcome
measures, data from a large community-based cohort and a long follow-up time. Additionally,
we included men from three different eras of military conflict and both military and civilian
controls.
Because combat exposure was based on self-report, recall bias could have affected results if
men in worse health differentially recalled their military experiences. Use of self-reported
combat experiences has precedent (2,41,42) with reports of high reliability (43) and validity,
with little evidence of falsification of traumatic experiences. (44) Still, we pursued ways to
validate this information. Unfortunately, exposure to specific traumatic experiences (e.g., being
under enemy fire, witnessing killing) is not captured in military service records, and veteran
status, age of enlistment, duration of service and service in combat zone were not available on
the majority of this cohort due to fire in National Archives Records Administration in St. Louis,
MO in 1973 that destroyed most World War II and Korean War era military service records.
Other validation methods were explored but deemed unfeasible as most sources (e.g.,
obituaries, POW lists, Medal of Honor lists, Agent Orange registry) are not population-based
and would not yield appropriate data on a representative sample.
Unmeasured psychological disorders such as post-traumatic stress disorder (PTSD) may have
played a role in observed relationships. (45–49) The development and persistence of PTSD
has been directly associated with combat exposure among veterans, (2,50–52) and with plasma
cortisol and other inflammatory markers. (53,54) While it would have been of interest to
provide results stratified on PTSD status, this information is not available in our data. Other
potential modifiers, though unavailable in these data, may include religious faith, other
psychiatric conditions and pre- and post-military traumatic experiences.
Left censoring is a potential concern in nearly all prospective cohort studies with an outcome
with inception in adulthood. While we cannot rule out differential post-service CVD mortality
preceding ARIC enrollment, given low CVD mortality rates in young adulthood, any bias, if
extant, is not expected to threaten the validity of our findings.
Right censoring is of greater potential concern. Combat exposure was not assessed until 12–
14 years after baseline, at which time 17% of male baseline participants had died. To address
this concern we conducted a pilot study on a subset of decedents from NC for whom veteran
status was recorded on death certificates. We found a small (2%) but not statistically significant
excess mortality among veterans, even after adjustment for age, race and education. We also
conducted a sensitivity analysis to estimate the extent to which differential survival may have
influenced observed results by comparing observed prevalence rates with those corrected for
selection bias. (55) Applying adjusted mortality rates from the pilot study to hypothetical data
with CHD as the outcome, and assuming that those who developed CHD were 1.5 times more
likely to die before providing data on military history than those who did not develop CHD,
our prevalence rate was underestimated by only 1.5%. Under a more extreme scenario – where
the difference in mortality is assumed to be higher than was found in the pilot study (e.g., 14%
for non-veterans and 18% for veterans, a 29% difference in mortality) and assuming those who
developed CHD are twice as likely to die prior to providing their military history – the observed
estimate still only differs from the corrected estimate by 7%. These results suggest that the
potential magnitude of survivorship bias, if extant, is small.
Conclusions
These findings suggest that, overall, middle-aged men with a history of distant military and
combat exposure are not at increased long-term cardiovascular risk; however, vulnerability to
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the ill effects of combat stress may be higher among men from lower socioeconomic
backgrounds. Future studies in other populations – particularly ones that include women and
persons from other races and ethnicities – should continue to explore socioeconomic and inter-
era differences in the long term health effects associated with military and combat exposure.
These findings provide key groundwork for future work on the lasting effects of traumatic
stress of large potential impact in public health, particularly given the continued pervasiveness
of military service and combat in our society today.
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Table 1
Profile of military and combat background reported by male veterans: ARIC Study participants who completed
the LC-SES interview (2001–2002).
Mean (SD) or n (%)
Non-Combat Veteran1 (N=2127) Combat Veteran1 (N=1178) p-value2
MILITARY HISTORY
 Mean (SD) Age in years at
induction into service
19.8 (2.4) 19.1 (2.2) <0.01
 Mean (SD) Years of service 3.1 (3.2) 4.9 (5.6) <0.01
 n (%) Served during World
War II era
314 (14.8) 478 (40.6) <0.01
  Korean War era 675 (31.7) 407 (34.6) 0.10
  Vietnam Conflict era 506 (23.8) 198 (16.8) <0.01
COMBAT HISTORY
 n (%) Served in combat zone 975 (82.8)
 n (%) Under enemy fire or
fired at enemy
700 (59.7)
 n (%) Saw wounded or killed 853 (72.7)
 n (%) Ever wounded or
missing
154 (13.1)
1
Combat Veterans are identified by a summary variable based on whether or not the individual served in the military and, if so, whether the individual
(1) served in a combat zone, (2) was under enemy fire or fired at enemy, (3) saw wounded or killed during war, and/or (4) was ever wounded during
war; Non-Combat Veterans are defined as those who served in the military but did not report any combat exposures (1–4).
2
p-values from Student t-tests for continuous variables and chi-square tests for categorical variables.
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%
 c
on
fid
en
ce
 in
te
rv
al
s)
 c
om
pa
re
 (1
) c
om
ba
t a
nd
 n
on
-c
om
ba
t v
et
er
an
s w
ith
 n
on
-v
et
er
an
s i
n 
on
e 
m
od
el
 a
nd
 (2
) c
om
ba
t w
ith
 n
on
-c
om
ba
t v
et
er
an
s i
n 
a 
se
pa
ra
te
 in
 a
 m
od
el
 e
xc
lu
di
ng
 n
on
-
ve
te
ra
ns
.
2 C
om
ba
t V
et
er
an
s a
re
 id
en
tif
ie
d 
by
 a
 su
m
m
ar
y 
va
ria
bl
e 
ba
se
d 
on
 w
he
th
er
 h
e 
se
rv
ed
 in
 th
e 
m
ili
ta
ry
 a
nd
, i
f s
o,
 w
he
th
er
 h
e 
(1
) s
er
ve
d 
in
 a
 c
om
ba
t z
on
e,
 (2
) w
as
 u
nd
er
 e
ne
m
y 
fir
e 
or
 fi
re
d 
at
 e
ne
m
y,
 (3
) s
aw
w
ou
nd
ed
 o
r k
ill
ed
 d
ur
in
g 
w
ar
, a
nd
/o
r (
4)
 w
as
 e
ve
r w
ou
nd
ed
 d
ur
in
g 
w
ar
; N
on
-C
om
ba
t V
et
er
an
s a
re
 d
ef
in
ed
 a
s t
ho
se
 w
ho
 se
rv
ed
 in
 th
e 
m
ili
ta
ry
 b
ut
 d
id
 n
ot
 re
po
rt 
an
y 
co
m
ba
t e
xp
os
ur
es
 (1
–4
).
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3 A
dj
us
te
d 
fo
r b
as
el
in
e 
ag
e 
an
d 
in
cl
ud
es
 in
te
ra
ct
io
n 
w
ith
 fa
th
er
’s
 e
du
ca
tio
n 
an
d 
ra
ce
.
4 A
dj
us
te
d 
fo
r b
as
el
in
e 
ag
e 
an
d 
fa
th
er
’s
 e
du
ca
tio
n 
an
d 
in
cl
ud
es
 in
te
ra
ct
io
n 
w
ith
 ra
ce
.
5 A
dj
us
te
d 
fo
r b
as
el
in
e 
ag
e 
an
d 
in
cl
ud
es
 in
te
ra
ct
io
n 
w
ith
 e
ra
 o
f s
er
vi
ce
.
6 A
dj
us
te
d 
fo
r b
as
el
in
e 
ag
e.
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